| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019338 |
| Receipt No. | R000022363 |
| Scientific Title | Clinical outcome of risedronate therapy for patients with Paget's disease of bone |
| Date of disclosure of the study information | 2015/10/15 |
| Last modified on | 2021/10/18 (Ver. 11) |
| Basic information | ||
| Public title | Clinical outcome of risedronate therapy for patients with Paget's disease of bone | |
| Acronym | Clinical outcome of risedronate therapy for patients with Paget's disease of bone | |
| Scientific Title | Clinical outcome of risedronate therapy for patients with Paget's disease of bone | |
| Scientific Title:Acronym | Clinical outcome of risedronate therapy for patients with Paget's disease of bone | |
| Region |
|
|
| Condition | ||
| Condition | Paget's disease of bone | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effectiveness of high dose resedronate for patients with Paget's disease of bone |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | ALP value |
| Key secondary outcomes | pain |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | risedronate 17.5mg | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | ALP value over normal range | |||
| Key exclusion criteria | not tolerated for risedronate | |||
| Target sample size | 15 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya University Hospital | ||||||
| Division name | Orthopaedic Surgery | ||||||
| Zip code | 4668550 | ||||||
| Address | 65-Tsurumai, Showa, Nagoya | ||||||
| TEL | 052-741-2111 | ||||||
| ynishida@med.nagoya-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya University Hospital | ||||||
| Division name | Orthopaedic Surgery | ||||||
| Zip code | 466-8550 | ||||||
| Address | 65-Tsurumai, Showa, Nagoya | ||||||
| TEL | 052-741-2111 | ||||||
| Homepage URL | |||||||
| ynishida@med.nagoya-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | JAPA:Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nagoya University |
| Address | Orthopaedic surgery, 65-Tsurumai |
| Tel | 0527412111 |
| ethics@med.nagoya-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋大学医学部附属病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | ||
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | Watching the progress of the case | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | ||
| Participant flow | ||
| Adverse events | ||
| Outcome measures | ||
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Analysis completed |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022363 |